Astria Therapeutics Inc Share Price

NASDAQ: ATXS

Small Cap

$7.26

-0.11

(-1.49%)

as on September 17, 2025 at 1:29 am IST

$₹

Astria Therapeutics Inc Stock Performance

as on September 17, 2025 at 1:29 am IST

Day's Low
Day's High
$7.22
Day's Price Range
$7.62
$7.26
0.55%
Downside
4.96%
Upside
52 Week's Low
52 Week's High
$3.56
52-Week Price Range
$12.92
$7.26
51.03%
Downside
77.96%
Upside

Astria Therapeutics Inc share price movements today

Previous Close: $7.37
Open: $7.33
Volume: 478.2K
Day's Low - High: $7.22 - $7.62
52 Week Low - High: $3.56 - $12.92

Astria Therapeutics Inc Historical Returns

1 Month Return: + 6.13 %
3 Month Return: + 27.54 %
1 Year Return: -36.78 %
3 Year Return: -26.71 %
5 Year Return: 0 %

Astria Therapeutics Inc Stock Fundamentals & Key Indicators

Check Astria Therapeutics Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$415.9M

EPS (TTM)

-2.1417

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

P/B Ratio

PEG Ratio

EBITDA

-32.4M

Revenue (TTM)

Profit Margin

0.00%

Return On Equity TTM

0.00%

Astria Therapeutics Inc vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Astria Therapeutics Inc with its industry peers.

Company	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin %
Astria Therapeutics Inc	BUY	$415.9M	NA	NA	0.00%
Alnylam Pharmaceuticals, Inc.	BUY	$60.5B	252.04%	-505.15	-12.96%
Beone Medicines Ltd	NA	$39.0B	NA	NA	-3.89%
Vertex Pharmaceuticals Incorporated	BUY	$100.3B	44.17%	27.85	31.86%
Regeneron Pharmaceuticals, Inc.	BUY	$59.6B	1.78%	14.1	31.37%

Stock Returns calculator for Astria Therapeutics Inc Stock including INR - Dollar returns

The Astria Therapeutics Inc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

Astria Therapeutics Inc investment value today

Current value as on today

₹67,998

Returns

₹32,002

(-32%)

Returns from Astria Therapeutics Inc Stock

₹36,870 (-36.87%)

Dollar Returns*

₹4,867 (+4.87%)

Analyst Recommendation on Astria Therapeutics Inc Stock

Based on 13 analysts

BUY

92.31%

Buy

7.69%

Hold

0.00%

Sell

Based on 13 analysts, 92.31% of analysts recommend a 'BUY' rating for Astria Therapeutics Inc. Average target price of $29.33

Astria Therapeutics Inc Share Price Target

Get share price movements and forecasts by analysts on Astria Therapeutics Inc.

What analysts predicted

75.25%UPSIDE

Target Price

$29.33

Current Price

$7.26

Analyzed by

13 Analysts

Target

$29.33

Astria Therapeutics Inc target price $29.33, a slight upside of 75.25% compared to current price of $7.26. According to 13 analysts rating.

Astria Therapeutics Inc Stock's Interest Amongst Investors

Search interest for Astria Therapeutics Inc Stock has decreased by -36% in the last 30 days, reflecting a downward trend in search activity.

Time period: August 18, 2025 to September 17, 2025

Change:-36% versus previous 30 day period

Astria Therapeutics Inc Quarterly Profit & Loss

All numbers in Millions USD

	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025
Total Revenue	-	-	-	-	-	-	-	-	-	-
Gross Profit	-	-	-	-	-	-	-	-	-	-
Operating Income	-13	-15	-20	-34	-24	-28	-29	-29	-36	-35
EBITDA	-13	-15	-20	-34	-24	-28	-29	-29	-36	-35
Interest Expense	2	-	-	2	-	-	-	-	-	-
Depreciation	-	-	-	-	-	-	-	-	-	-
Income Before Tax	-11	-12	-17	-31	-19	-24	-24	-25	-33	-33
Income Tax Expense	-2	-2	0	0	0	-	-	0	-	-
Net Income	-11	-12	-17	-31	-19	-24	-24	-25	-33	-33
Net Profit Margin	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%

Astria Therapeutics Inc Annual Profit & Loss

All numbers in Millions USD

	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Total Revenue	0	-	-	-	-	-	-	-
Gross Profit	0	0	0	-	-	-	-	-
Operating Income	-27	-26	-27	-37	-194	-53	-83	-111
EBITDA	-26	-25	-26	-37	-194	-51	-83	-94
Interest Expense	0	0	-	0	0	1	-	-
Depreciation	0	0	0	-	-	-	-	-
Income Before Tax	-27	-25	-26	-37	-194	-51	-72	-94
Income Tax Expense	0	0	0	0	-164	-1	0	-
Net Income	-27	-25	-26	-37	-194	-50	-72	-94
Net Profit Margin	-5472.80%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%

Astria Therapeutics Inc Quarterly Cash Flow

All numbers in Millions USD

	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025
Net Income	-12	-17	-31	-19	-24	-24	-25	-33	-33
Operating Cash Flow	-10	-14	-30	-19	-16	-27	-17	-34	-36
Investing Cash Flow	-57	0	-2	-126	-68	6	-3	28	57
Financing Cash Flow	0	0	87	141	0	15	-	-	-
Change in Cash	-68	-14	55	-3	-84	-6	-21	-5	21

Astria Therapeutics Inc Annual Cash Flow

All numbers in Millions USD

	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Net Income	-36	-27	-25	-26	-37	-194	-51	-72	-94
Operating Cash Flow	-32	-26	-23	-26	-32	-30	-43	-68	-81
Investing Cash Flow	-15	14	-21	-4	6	-12	-167	135	-191
Financing Cash Flow	9	4	44	25	40	104	144	88	157
Change in Cash	-39	-7	-1	-5	14	61	-65	155	-115

Global Institutional Holdings in Astria Therapeutics Inc

Funds	Holdings
FMR Inc	12.29%
Perceptive Advisors LLC	11.49%
RA Capital Management, LLC	9.05%
Vestal Point Capital LP	7.41%
BlackRock Inc	6.78%

See all

Insights on Astria Therapeutics Inc

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

NO EFFECT
Against Peers
In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 116.5% return, outperforming this stock by 143.2%
NO EFFECT
Against Peers
In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 68.1% return, outperforming this stock by 104.9%
NEGATIVE IMPACT
Price Dip
In the last 7 days, ATXS stock has moved down by -2.9%

About Astria Therapeutics Inc

Astria Therapeutics, Inc. is a biopharmaceutical company focused on the discovery, development and commercialization of novel therapeutics for allergic and immunological diseases. Its lead product candidate is Navenibart, a potential monoclonal antibody inhibitor of plasma kallikrein in clinical development for the treatment of hereditary angioedema (HAE), a rare, autosomal dominant genetic disorder. Its second product candidate is STAR-0310, a monoclonal antibody OX40 antagonist that is in clinical development for the treatment of atopic dermatitis (AD), an immune disorder associated with loss of skin barrier function and itching. It owns five patent families directed to navenibart. The first patent family is directed to the composition of matter of navenibart and its use in treating various plasma kallikrein associated disorders, including HAE. In the second patent family, it is directed to methods of treating various plasma-kallikrein-associated disorders, including HAE.

Organisation	Astria Therapeutics Inc
Headquarters	22 Boston Wharf Road, Boston, MA, United States, 02210
CEO	Ms. Jill C. Milne Ph.D.
E-voting on shares	Click here to vote

Key Management of Astria Therapeutics Inc

Name	Title
Ms. Jill C. Milne Ph.D.	Co-Founder, CEO, President & Director
Dr. Christopher J. Morabito M.D.	Chief Medical Officer
Ms. Keri McGrail	Chief Human Resources Officer
Ms. Andrea L. Matthews	Chief Business Officer
Mr. Andrew A. Komjathy	Chief Commercial Officer
Mr. Benjamin S. Harshbarger J.D.	Chief Legal Officer
Mr. Noah C. Clauser CPA	CFO & Treasurer
Mr. John Ruesch	Senior Vice President of Pharmaceutical Sciences & Technical Operations
Ms. Rafif Dagher	Senior VP and Head of Discovery, Nonclinical Development & Translational Research

FAQs

What is Astria Therapeutics Inc share price today?

Astria Therapeutics Inc share price today is $7.26 as on September 17, 2025 at 1:29 am IST at the close of the market. Astria Therapeutics Inc share today touched a day high of $7.62 and a low of $7.22.

What is the 52 week high and 52 week low for Astria Therapeutics Inc share?

Astria Therapeutics Inc share touched a 52 week high of $12.92 on September 20, 2024 and a 52 week low of $3.56 on April 9, 2025. Astria Therapeutics Inc stock price today i.e. September 17, 2025 at 1:29 am IST is closed at $7.26,which is 43.81% down from its 52 week high and 104.22% up from its 52 week low.

What is Astria Therapeutics Inc's market capitalisation today?

Astria Therapeutics Inc market capitalisation is $0.00T as on September 17, 2025 at 1:29 am IST.

How to invest in Astria Therapeutics Inc Stock (ATXS) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for Astria Therapeutics Inc on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Astria Therapeutics Inc Shares that will get you 0.2066 shares as per Astria Therapeutics Inc share price of $7.26 per share as on September 17, 2025 at 1:29 am IST.

What is the minimum amount required to buy Astria Therapeutics Inc Stock (ATXS) from India?

Indian investors can start investing in Astria Therapeutics Inc (ATXS) shares with as little as ₹88.042 or $1 (as of September 17, 2025 at 4:44 pm IST) using the INDmoney app.
For example: If you want to invest $10 or ₹880.42 in Astria Therapeutics Inc stock (as per the Rupee-Dollar exchange rate as on September 17, 2025 at 4:44 pm IST). Based on Astria Therapeutics Inc share’s latest price of $7.26 as on September 17, 2025 at 1:29 am IST, you will get 1.3774 shares of Astria Therapeutics Inc. Learn more about fractional shares .